# Orbit Discovery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orbit-discovery

- Industry: Biotechnology
- Headquarters: Oxford, UK
- Website: www.orbitdiscovery.com
- Total disclosed funding: $9.5M
- Latest round: Series A (May 23, 2018)
- Investors on record: 5

## About

Based in the UK, Orbit Discovery Ltd. specializes in peptide discovery solutions, employing advanced technologies to develop high-affinity peptide conjugates for targeted therapeutic applications.Orbit Discovery Ltd. was founded in 2015 and operates from Oxford, UK. The company focuses on peptide discovery for biopharmaceutical applications and has completed three deals to date. In July 2021, Orbit Discovery raised GBP 5.58 mn in a funding round led by Oxford Sciences Enterprises, with additional participation from Borealis Ventures and Perivoli Innovations. Neil Butt serves as CEO, guiding the company through its strategic development.Orbit Discovery specializes in peptide discovery solutions, leveraging advanced bead-based technology and flow cytometry to identify high-affinity peptide conjugates for precise radionuclide delivery. Their core product offerings include diverse peptide libraries that enhance target specificity while minimizing off-target effects, particularly for tumor-specific targets. The company employs a sophisticated screening platform that integrates microfluidics for direct functional screening against reporter cells, ideal for identifying GPCR agonists and antagonists. Orbit Discovery's services cater to clients in the biopharmaceutical sector focusing on targeted therapies, such as RNA delivery systems and PROTACs, serving a global clientele in North America and Europe.Orbit Discovery generates revenue through partnerships and collaborations in the biopharmaceutical industry, providing customized peptide discovery and validation services based on specific client needs. Contracts involve commissioned tasks like screening peptide libraries for high-affinity binders and functional assays tailored to therapeutic targets. Their pricing structure varies based on service complexity, reflecting the bespoke nature of offerings for pharmaceutical companies and research organizations.In July 2021, Orbit Discovery Ltd. raised GBP 5.58 mn in venture funding to accelerate its growth trajectory. The company plans to launch new products designed around innovative peptide conjugate solutions, targeting expansion into new markets, including North America and Europe, by 2024. The recent funding will be utilized to support these initiatives and enhance their development capabilities.

## Funding rounds

- Series A, May 23, 2018, $9.3M — Borealis Ventures, Oxford Sciences Enterprises, Perivoli Innovations, RT Ventures
- Seed, Nov 27, 2015, $0.1M — Oxford Technology Management

## Investors

- Oxford Technology Management (https://capitalatlas.ai/funds/oxford-technology-management) — Seed
- Borealis Ventures (https://capitalatlas.ai/funds/borealis-ventures) — Series A
- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Series A
- Perivoli Innovations (https://capitalatlas.ai/funds/perivoli-innovations) — Series A
- RT Ventures — Series A